-
Sort By
-
Newest
-
Newest
-
Oldest
Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
ASX holds onto gains, retail pain on show at Myer (ASX:MYR), another sell off to end the week The ASX 200 (ASX:XJO) managed to stave off weakness in the afternoon, finishing 0.5%, despite a much stronger lead from the US markets. The telecommunications and materials sectors including the likes of Telstra (ASX:TLS) and BHP (ASX:BHP)…
It’s back: US markets down over 4%, dividends the story of the day, a deal with the devil The ASX 200 (ASX:XJO) finished another 0.8% higher, with everything but the IT, materials and utilities sectors adding to the rally. As reporting season comes to an end, dividend payments are driving daily movements with BHP Group…